Staff Directory

Izzat Fahimuddin Bin Mohamed Suffian

Academic Qualification

  • PhD in Pharmaceutical Science Research - Doctor of Philosophy, King's College London
  • Bachelor of Engineering - Bachelor Degree, Kobe University

Izzat Fahimuddin Bin Mohamed Suffian (Dr.)

Assistant Professor
IIUM Kuantan Campus


Expert Profile

Dr. Izzat Fahimuddin Bin Mohamed Suffian joined Kulliyyah of Pharmacy as a lecturer in November 2016. He is currently an Assistant Professor in Drug Delivery and Nanomedicine. He was awarded the Look East Policy Programme Scholarship from the Public Service Department, Government of Malaysia (2006-2012) to complete his first degree in Bachelor of Engineering in Chemical Science and Engineering at the Department of Chemical Science and Engineering, Faculty of Engineering, Kobe University (Japan). He worked briefly as a research assistant at the Biochemical Engineering Laboratory, Kobe University where he focussed on studying the role of arginine in the arginine-rich domain of Hepatitis B Virus core particles on cell uptake using in vitro models. He was also awarded the Excellent Student Programme (PPC) Scholarship from Public Service Department, Government of Malaysia (2012-2016) to complete his PhD in Pharmacology and Pharmaceutical and Analytical Science from King’s College London, United Kingdom, which involves engineering targeted hepatitis B virus core particles for cancer therapy. During his PhD studies, Dr. Izzat was awarded the prestigious Wellcome Image Awards, which recognise the creators of the most informative, striking and technically excellent images that communicate significant aspects of biomedical science in 2014 and 2016. As well as being a previous Wellcome Image Award winner, he has also won a science photography competition organised by the Engineering and Physical Sciences Research Council (EPSRC) in 2014. He has developed an extensive experience in designing and developing novel nanoscale delivery systems including virus-like particles and liposomes. His current work involves pre-clinical translation of novel nanomaterials designed specifically for drug, siRNA, plasmid and radionuclide delivery for therapeutic or diagnostic applications. He reported the potential of Hepatitis B Virus core particles as nanocarriers in targeting HER2-positive metastatic abdominal cancer following intra-peritoneal administration in vivo. In 2020, Izzat has been selected as a fellow with other 52 among 300 academics from all over public universities in Malaysia, under a programme called CEO@Faculty Programme 2.0 Cycle 3. This programme is organised by Ministry of Education, aimed at exposing university lecturers below 40 years old with a doctoral degree to the rudiments and operations of the industry. The programme celebrates the CEOs who have voluntarily accepted the task to coach young university lecturers to become future leaders. Currently, Izzat is attached with Datuk Nora A. Manaf, Chief Group Human Capital, Maybank Group Berhad, under this programme.   

Area of Specialisation

  • Medical And Health ~ Medical And Health Sciences ~ Biomedical Sciences ~ Nanomedicine - Drug delivery

Professional Membership

  • 2019 - 2020: Member of Profesional Body / Association: (Co-opted Exco Member), The Malaysia Local Chapter of the Controlled Release Society (MyCRS)

Teaching Responsibilities

COSMETICS & COSMECEUTICALS 2023/2024 2022/2023
Drug Abuse 2017/2018
E-COMMERCE 2023/2024
IMMUNOLOGY 2019/2020 2018/2019 2017/2018
NUCLEAR PHARMACY 2024/2025 2023/2024 2022/2023 2020/2021 2019/2020 2018/2019 2017/2018
PHARMACEUTICAL MICROBIOLOGY 2018/2019 2017/2018 2016/2017
RESEARCH PROJECT 1 2021/2022 2020/2021 2019/2020 2018/2019 2017/2018
RESEARCH PROJECT 2 2021/2022 2020/2021 2019/2020 2018/2019
RESEARCH PROJECT-LITERATURE SEARCH 2020/2021 2019/2020 2018/2019
STERILE PROCESSES AND PRODUCTS 2023/2024 2022/2023 2021/2022


Novel In Silico Selex In Designing Aptamer Hairpin For In Vitro Detection Of He4: An Ovarian Cancer Biomarker.
Ph.D In Progress Main Supervisor
The Formulation Of 5-Fluorouracil-Loaded Hydrogel-Nanoparticles Hybrid For Treatment Of Oral Squamous Cell Carcinoma .
Master Completed 2023 Main Supervisor
Skin Barrier Repair Functions Of Benincasa Hispida Seed Extract In Atopic Dermatitis.
Master Completed 2023 Co-supervisor
Assessment Of Suitable Alginate Beads For Probiotic Encapsulation Enhancing Its Viability And Stability.
Master Completed 2023 Co-supervisor
Mechanism And Specificity Of Angiotensin Converting Enzyme Inhibition Activity By Syzygium Polyanthum Wight (Walp.) Leaves.
Master Completed 2021 Co-supervisor
Development And Characterisation Of Capsaicin-Encapsulated Polymeric Hydrogel Nanocarrier For In Vitro Cancer Therapy.
Master In Progress Main Supervisor

Research Projects

2019 - 2023 Assessment on suitable hydrocolloids for probiotic encapsulation enhancing its viablity and stability
2018 - 2020 In vitro effect of Tamarindus indica as a potential anti-larvae of screwworm maggots obtained from goats with myiasis
2017 - 2022 Rheological and Physical Properties characterization of nanoparticles-hydrogel for topical oral drug of oral cancer (targeted drug delivery)
2021 - Present Hepatotoxicity Studies of Eltrombopag-Loaded PLGA_PEG polymeric Nanocapsules in ITP-Induced Mice Model
2021 - Present Optimisation, Assembly, Testing, Validation, and Scaling Up of the Nanotech COVID19 Rapid Test Kit
2019 - Present Preparation, characterisation and cytotoxicity assay of damnacanthal-loaded polymeric nanocapsules for breast cancer therapy
2017 - Present Formulation of 5-Fluorouracil-loaded EGFR-Targeted Hydrogel-Nanocapsule Hybrids for Oral Squamous Cell Carcinoma Therapy

Award & Recognition

02 May, 2017 Best Paper Presentation - ASIA International Multidisciplinary Conference 2017 International



2024 DNA aptamers: the game-changers in diagnostics. Revelation and Science, 14 (01) pp. 59-74
2024 Three-dimensional structure of Human Epididymis Protein 4 (HE4): a protein modelling of an ovarian cancer biomarker through in silico approach. Journal of Tropical Life Science, 14 (2) pp. 331-348
2023 Poly lactic-co-glycolic acid nanoparticles: flow rates and gauge sizes influence the droplet surface tension and particle sizing. Journal of Research in Nanoscience and Nanotechnology, 9 (1) pp. 1-12
2023 Qualitative assessment the effect of glucose on hydrogel used for nanomedicine drug delivery. Revelation and Science, 13 (2) pp. 30-38
2023 Rheological assessments on alginate and carrageenan as nanoparticle carriers for topical oral cancer drug. Journal of Tropical Life Science, 13 (2) pp. 239-246
2022 Angiotensin Converting Enzyme (ACE) inhibitionactivity by Syzygium polyanthum Wight (Walp.) leaves: mechanism and specificity. Pharmacognosy Journal, 14 (1) pp. 763-84
2022 Qualitative physical assessment on the effects of salt on potential hydrogels used in nanoparticle drug delivery. Revelation and Science, 12 (2) pp. 79-94
2021 Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours. Advanced Drug Delivery Reviews, 180 () pp. 1-19
2021 Hydrogel-nanoparticle hybrids for biomedical applications: principles and advantages. Nanomedicine, 16 (2) pp. 81-84
2021 LCMS dataset on compounds in syzygium polyanthum (wight) walp. leaves variant from the East coast of Peninsular Malaysia. Data in Brief, 39 () pp.
2020 Hydrogel–nanoparticle hybrids for biomedical applications: principles and advantages. Nanomedicine, 16 (2) pp. 81-84
2019 Development of biodegradable sustained-release damnacanthal nanocapsules for potential application in in-vitro breast cancer studies. Pakistan Journal of Pharmaceutical Sciences, 32 (5) pp. 2155-2162
2018 Engineering human epidermal growth receptor 2‑Targeting hepatitis B virus core nanoparticles for siRNA delivery in vitro and in vivo. ACS Applied Nano Materials, xx (xx) pp. 1-14
2017 Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo. Biomaterials, 120 () pp. 126-138
2017 Yield optimisation of hepatitis B virus core particles in e. coli expression system for drug delivery applications. Scientific Reports, 7 () pp. 1-9
2015 Cationic liposome- multi-walled carbon nanotubes hybrids for dual siPLK1 and doxorubicin delivery in vitro. Pharmaceutical Research, 32 (10) pp. 3293-3308
2015 Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles. Nanobiotechnology, 13 () pp.
2011 Granting specificity for breast cancer cells using a hepatitis B core particle with a HER2-targeted affibody molecule. Journal of Biochemistry, 153 (3) pp. 251-256
Conference or Workshop Item

2021 Angiotensin-converting enzyme inhibition activity and LCMS analysis of Syzygium polyanthum (Wight) Walp leaves. In: National Symposium on Essential Oils, Plants, Cosmetic and Health,
2021 Mechanism of angiotensin converting enzyme (ACE) inhibition by Syzygium polyanthum wight (WALP.) leaves. In: IIUM Research Day 2021: An International Online Event for Life Sciences,
2021 Molecular binding interaction of angiotensin converting enzyme and 1-galloyl glucose, the major compound in Syzygium polyanthum leaves. In: 7th International Conference on Advancement in Science and Technology (iCAST2021),
Book Section

2021 In vitro angiotensin-converting enzyme (ACE) inhibition activity of Syzygium polyanthum leaves and its inhibition mechanism. In: Frontiers, ISBN: 978-2-88971-008-9, pp.